Edifoligide (Corgentech, South San Francisco, CA), an oligonucleotide that had shown some capacity for vein-graft protection in earlier animal and clinical studies, turned out to be "no more effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results